UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular basis of familial hypercholesterolemia in Poland – update from the Polish national centre of diagnostics and treatment of familial hypercholesterolemia

Atherosclerosis, 2016-09, Vol.252, p.e38-e38

2016

Volltextzugriff (PDF)

Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia

European journal of clinical pharmacology, 1991, Vol.40 (1), p.33-41

1991

Volltextzugriff (PDF)

Valproic acid amide in the treatment of affective and schizoaffective disorders

Journal of affective disorders, 1984-02, Vol.6 (1), p.115-121

1984

Volltextzugriff (PDF)

Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates

Kardiologia polska (1957), 2005-06, Vol.62 Suppl 2, p.II45-II50

2005

Volltextzugriff (PDF)

Changes in the intake of vitamins and minerals by men and women with hyperlipidemia and overweight during dietetic treatment

European journal of clinical nutrition, 2002-12, Vol.56 (12), p.1162-1168

2002

Volltextzugriff (PDF)

Modification of low density lipoproteins from hypertriglyceridemic patients by macrophages in vitro and the effect of bezafibrate treatment

Atherosclerosis, 1989-10, Vol.79 (2), p.261-265

1989

Volltextzugriff (PDF)

Preventive effect of valproic acid amide in affective diseases

Psychiatria polska, 1985-01, Vol.19 (1), p.23

Kłosiewicz, L

1985

Volltextzugriff (PDF)

Valproic acid derivatives: toxicity and adverse effects

Psychiatria polska, 1987-01, Vol.21 (1), p.57

1987

Volltextzugriff (PDF)

Rationalization of nutrition in treatment of metabolic diseases. New problems in light of progress in science

Polskie archiwum medycyny wewne̦trznej, 2001, Vol.105 Suppl, p.211

2001

Volltextzugriff (PDF)

Complications occuring in the course of lithium salts treatment as a cause for the interruption of treatment

Psychiatria polska, 1978-05, Vol.12 (3), p.397

1978

Volltextzugriff (PDF)

Some causes for the failure of lithium therapy in the prophylaxis of affective disturbances

Psychiatria polska, 1978-05, Vol.12 (3), p.391

1978

Volltextzugriff (PDF)

Principles of pharmacologic treatment for hyperlipoproteinemia

Wiadomości lekarskie (1960), 1990-08, Vol.43 (15-16), p.821

Kłosiewicz-Latoszek, L

1990

Volltextzugriff (PDF)

Do antioxidant vitamins protect from arteriosclerosis?

Kardiologia polska (1957), 1992-06, Vol.36 (6), p.369

1992

Volltextzugriff (PDF)

Efficacy and safety of treating hyperlipidemia type II with fluvastatin in patients with arterial hypertension

Polski merkuriusz lekarski, 1997-07, Vol.3 (13), p.13

1997

Volltextzugriff (PDF)

Comparative studies on the influence of different fibrates on serum lipoproteind in endogenous hyperlipoproteinaemia

European journal of clinical pharmacology, 1991, Vol.40 (1), p.33-41

1991

Volltextzugriff (PDF)

EEG pattern of sleep in patients with bipolar affective disorder during treatment with lithium salts

Psychiatria polska, 1983-07, Vol.17 (4), p.295

1983

Volltextzugriff (PDF)

Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders

Psychopharmacology bulletin, 1984, Vol.20 (1), p.151

1984

Volltextzugriff (PDF)

Fibrates in the treatment of hyperlipidemia

Wiadomości lekarskie (1960), 1993-11, Vol.46 (21-22), p.872

1993

Volltextzugriff (PDF)

Epidemiology and prevention of arterial hypertension in Poland

Blood pressure, 2005-12, Vol.14 (S2), p.10-16

2005

Volltextzugriff (PDF)

Arteriosclerosis risk factors: new aspects

Wiadomości lekarskie (1960), 1988-02, Vol.41 (3), p.169

1988

Volltextzugriff (PDF)

Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins

Wiadomości lekarskie (1960), 1993-08, Vol.46 (15-16), p.581

1993

Volltextzugriff (PDF)

Arteriosclerosis. IV. Treatment of dyslipoproteinemia

Wiadomości lekarskie (1960), 1985-09, Vol.38 (17), p.1251

1985

Volltextzugriff (PDF)

Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia

Wiadomości lekarskie (1960), 1985-08, Vol.38 (16), p.1179

1985

Volltextzugriff (PDF)

Arteriosclerosis. II. Pathogenesis of dyslipoproteinemia

Wiadomości lekarskie (1960), 1985-08, Vol.38 (15), p.1097

1985

Volltextzugriff (PDF)

Treatment of hypercholesterolemia. I. Do side effects of exist when cholesterol levels are reduced?

Wiadomości lekarskie (1960), 1992-12, Vol.45 (23-24), p.934

1992

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(54)
Buchkapitel
(1)

Sprache

Polnisch
(32)
Englisch
(23)

Erscheinungsjahr

n.n

Thema

Humans
(47)
Male
(24)
Female
(23)
Middle Aged
(23)
Adult
(22)
Aged
(12)
Cholesterol - Blood
(12)
Science & Technology
(10)
Life Sciences & Biomedicine
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Risk Factors
(8)
Lipoproteins, Vldl - Blood
(7)
Triglycerides - Blood
(7)
Arteriosclerosis - Etiology
(5)
Lipoproteins - Blood
(5)
Lipoproteins, Ldl - Blood
(5)
Pharmacology. Drug Treatments
(5)
Apolipoproteins - Blood
(4)
Arteriosclerosis - Prevention & Control
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular basis of familial hypercholesterolemia in Poland – update from the Polish national centre of diagnostics and treatment of familial hypercholesterolemia

Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia

Valproic acid amide in the treatment of affective and schizoaffective disorders

Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates

Changes in the intake of vitamins and minerals by men and women with hyperlipidemia and overweight during dietetic treatment

Modification of low density lipoproteins from hypertriglyceridemic patients by macrophages in vitro and the effect of bezafibrate treatment

Preventive effect of valproic acid amide in affective diseases

Valproic acid derivatives: toxicity and adverse effects

Rationalization of nutrition in treatment of metabolic diseases. New problems in light of progress in science

Complications occuring in the course of lithium salts treatment as a cause for the interruption of treatment

Some causes for the failure of lithium therapy in the prophylaxis of affective disturbances

Principles of pharmacologic treatment for hyperlipoproteinemia

Do antioxidant vitamins protect from arteriosclerosis?

Efficacy and safety of treating hyperlipidemia type II with fluvastatin in patients with arterial hypertension

Comparative studies on the influence of different fibrates on serum lipoproteind in endogenous hyperlipoproteinaemia

EEG pattern of sleep in patients with bipolar affective disorder during treatment with lithium salts

Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders

Fibrates in the treatment of hyperlipidemia

Epidemiology and prevention of arterial hypertension in Poland

Arteriosclerosis risk factors: new aspects

Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins

Arteriosclerosis. IV. Treatment of dyslipoproteinemia

Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia

Arteriosclerosis. II. Pathogenesis of dyslipoproteinemia

Treatment of hypercholesterolemia. I. Do side effects of exist when cholesterol levels are reduced?

Suchergebnisse filtern